Biovail Corp. shares sank Friday after the company said the Food and Drug Administration will not approve a once-daily salt formulation of its depression treatment bupropion.
From: biz.yahoo.com
Biovail Falls After FDA Ruling
Posted by Ruslan Abuzant at 11:26 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment